Загрузка...
Effects of denosumab on bone density, mass and strength in women with postmenopausal osteoporosis
Denosumab is a human monoclonal antibody which specifically blocks receptor activator of nuclear factor κB ligand and is a very potent antiresorptive drug. Its efficacy in reducing the risk of vertebral, hip and nonskeletal fracture has been proven in a large prospective, randomized multicenter stud...
Сохранить в:
| Опубликовано в: : | Ther Adv Musculoskelet Dis |
|---|---|
| Главный автор: | |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
SAGE Publications
2015
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4426099/ https://ncbi.nlm.nih.gov/pubmed/26029270 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1759720X15579189 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|